Search

Why is Diversity, Equity and Inclusion important to us?

Better Access to Healthcare for Indigenous Peoples

Indigenous Peoples often experience poor access to health care. Our initiatives from Canada and New Zealand aim to overcome the gap.

Health Equity: No distance is too far

India is hosting the G20 summit. The leading theme of the G20 summit emphasizes health equity and sustainability as part of the agenda. How we provide access to healthcare for rural areas in India.

Work life wellness

We provide you with a range of benefits and services, including counselling, exercise classes, social events to help you stay mentally and physically fit.

Circular economy

Boehringer Ingelheim strives to use resources for as long as possible, process them for reuse or recycle them.

Generalized pustular psoriasis (GPP): a rare, chronic, systemic disease

A rare, chronic, systemic autoinflammatory disease that can be life-threatening if left untreated.

How do our donations for Ukraine help?

The war in Ukraine continues to cause suffering and hardship. The Polish and the German Red Cross – also supported by donations from us – help to the best of their ability.

Boehringer-Ingelheim's-half-year-figures-2021

Press release on Boehringer Ingelheim's half-year figures 2021. Business development from January to June 2021.

Our people

Ambition. Passion. Integrity. Commitment. Empathy. Individuality. We expect these qualities at all levels.

Learning and development

We help people grow professionally by maximizing our talent and giving them room to evolve within the company.

Plasmid DNA Production | Bioxcellence

Discover our range of plasmid DNA production solutions from research to GMP.

Really Digital, Mr Hach!

The Head of User Experience and SCRUM at Boehringer Ingelheim’s digital lab BI X offers a glimpse into his work and motivation.

Our Expectations

We expect adherence to exemplary ethical and professional conduct both within the company and from our business partners.

Patient centricity and site centricity in clinical trials

We are partnering with patients, caregivers and trial site staff to design and conduct our clinical trials, to provide a better experience for all.

NexGard

Delivered in a highly palatable beef-flavoured chew that kills adult fleas and is indicated for the treatment and prevention of flea infestations and the treatment and control of tick infestations in dogs and puppies.

Solidarity with Ukraine

Our company condemns the military aggression against Ukraine and is committed to helping those in need in the longer term with monetary and in kind donations

Tomorrow's leaders

We invest in our employees by giving them leadership training that enhances their skills and prepares them for future roles within the organization.

Uncommon_Mutations_Database

New database of published clinical outcomes from patients with uncommon EGFR mutations in advanced NSCLC treated with afatinib is available for global clinician use

Living with pulmonary fibrosis and finding hope

From caregiver to co-founder of the European Pulmonary Fibrosis Federation, Liam Galvin shares about his experience, and the impact of ongoing research

Rabisin® / Imrab®

Rabisin® is used for the active immunisation of dogs and cats to reduce mortality and clinical signs due to rabies infection.

Boehringer Ingelheim half-year results 2023

First half of 2023: Boehringer Ingelheim sees strong growth and expansion in key therapy areas

In-Reach Africa initiatives successfully completed

We are proud to report the successful completion of Kuza Afya and Tiba Yako, two of our In-Reach Africa initiatives.

Rabisin® / Raboral V-RG®